1. Generics Bulletin
  2. >>Products
  3. >>Biosimilars

Richter Confirms European Tocilizumab Filing

Mochida-Partnered RoActemra Biosimilar Submitted To EMA

 
• By Dean Rudge

Gedeon Richter has filed its Mochida-partnered tocilizumab biosimilar rival to RoActemra with the European Medicines Agency. But with several biosimilars already having won approval, the market could be competitive.

European Medicines Agency Sign Amsterdam
Gedeon Richter has filed its tocilizumab biosimilar with the EMA • Source: Alamy

Gedeon Richter has announced that a filing for its RGB-19 Mochida-partnered biosimilar rival to RoActemra (tocilizumab) has been accepted for review by the European Medicines Agency.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Biosimilars

More from Business